Legend:
CC = Vancouver Convention Centre
F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
343
Tue, 7/31/2018,
10:30 AM -
12:20 PM
CC-West 213
SPEED: Tests, Trials, Biomarkers, and Other Topics in Biometrics — Contributed Speed
Biometrics Section , Biopharmaceutical Section , ENAR
Chair(s): Sayan Dasgupta, Fred Hutchinson Cancer Research Center
Poster Presentations
for this session.
10:35 AM
Some T-Tests for N-Of-1 Trials with Serial Correlation
Ji-Ling Tang, University of Arkansas for Medical Sciences ; Reid D. Landes, University of Arkansas for Medical Sciences; Anne Holbrook, McMaster University; Mark S Mennemeier, University of Arkansas for Medical Sciences; J. Tyler Floyd, University of Central Arkansas
10:40 AM
Some T-Tests for N-Of-1 Trials with Serial Correlation: Correction Factors for Trials with Few Observations
Reid D. Landes, University of Arkansas for Medical Sciences ; Ji-Ling Tang, University of Arkansas for Medical Sciences; Mark S Mennemeier, University of Arkansas for Medical Sciences; J. Tyler Floyd, University of Central Arkansas; Anne Holbrook, McMaster University
10:45 AM
Hybrid Cluster-Individual Randomization Allocation
Yi-Fan Chen, University of Illinois at Chicago ; Jonathan Yabes, University of Pittsburgh
10:50 AM
Adjusting a Finite Population Block Kriging Estimator for Imperfect Detection
Matthew Higham
10:55 AM
Using Logistical Regression to Build a Better Diathesis Model of Dupuytren's Contracture Recurrence
Brian Cohen, ACI Clinical
11:10 AM
A Two-Stage Method to Analyze Multivariate Cluster Biomarkers in Prediction on a Single Binary Outcome
Xiaoying Yu, University of Texas Medical Branch at Galveston ; Wenyaw Chan, University of Texas Health Science Center at Houston; Gracie Vargas, University of Texas Medical Branch at Galveston; Rahul Pal, University of Texas Medical Branch at Galveston
11:15 AM
An Estimation Method for Enzyme Kinetic Model Parameters Based on Bayesian Approach
Boseung Choi, Korea University ; Jae Kyoung Kim, Korea Advanced Institute of Science and Technology; Grzegorz A Rempala, The Ohio State University
11:20 AM
Statistical Precision of Time-to-Event Endpoint in Single Arm Observational Study Using Monte Carlo Simulation
Meijing Wu, AbbVie ; Hongwei Wang, AbbVie Inc; Yabing Mai, AbbVie, Inc; Dajun Tian, Chiltern
11:30 AM
Multiple Testing Procedure Consideration in Clinical Trials
Rachael Wen, Sanofi
11:35 AM
Practical Determining the Late Effect Parameter in Fleming-Harrington Test When a Delayed Treatment Effect Is Predicted
Yuichiro Kaneko, Astellas Pharma ; Satoshi Morita, Kyoto University
11:40 AM
Inferring Networks from Personal, Dense, Dynamic Data Clouds of Biological and Quantified-Self Data
Elisa Sheng, Arivale
11:45 AM
Optimal Testing Configurations for Group Testing
Brianna D. Hitt, University of Nebraska-Lincoln ; Christopher R. Bilder, University of Nebraska-Lincoln; Joshua M. Tebbs, University of South Carolina; Christopher S. McMahan, Clemson University
11:50 AM
Common Risk Difference Test and Interval Estimation of Risk Difference for Stratified Bilateral Correlated Data
Xi Shen, State University of New York At Buffalo ; Changxing Ma, State University of New York At Buffalo; Guoliang Tian, Southern University of Science and Technology; Kam Chuen Yuen, The University of Hong Kong
11:55 AM
Functional Data Analysis in Dose-Adjusted Tacrolimus Trough Concentration Modeling: A New Method to Compare Intrapatient Variance Between Patient Cohorts
Janet Kim, Astellas Pharma Global Development, Inc. ; Sam Wilson, Astellas Pharma Global Development, Inc.; Jason J Schwartz, Astellas Pharma Global Development, Inc.
12:05 PM
Design Considerations When Comparing Control, Treatment, and Treatment Plus in Randomized Trials
Abigail Shoben, Ohio State University
